IP Library Granted Patent US 8,653,007
Granted Patent B2
US 8,653,007 · App. 13/441,208 · Granted Feb 18, 2014

Compositions, methods and related uses for cleaving modified DNA

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,653,007
App. No.
13/441,208
Granted
Feb 18, 2014
Kind
B2
Abstract

Compositions, methods and related uses are provided relating to cleaving modified DNA. For example, a set of DNA fragments obtainable by enzymatic cleavage of a large DNA is described where at least 50% are similarly sized and have a centrally positioned modified nucleotide. In addition, an enzyme preparation is provided that includes one or more enzymes that recognize a modified nucleotide in a DNA and cleave the DNA at a site that is at a non-random distance from the modified nucleotide. The one or more enzymes are further characterized by an N-terminal conserved domain with greater than 90% amino acid sequence homology to WXD(X) 10 YXGD. The related uses include creating a methylome, methods of purifying DNA fragments containing a modified nucleotide and diagnostic applications.

Claims (13)

1. A composition comprising a plurality of similar sized double-stranded fragments, the fragments further characterized by:

(a) staggered ends; and

(b) a centrally positioned methylated or hydroxymethylated cytosine proximal to a guanine;

wherein the fragments are obtainable by in vitro enzymatic cleavage of a large DNA, the large DNA comprising genomic DNA.

2. The composition according to claim 1 , wherein plurality of fragments are isolated.

3. The composition according to claim 1 , wherein the large DNA is at least 100 nucleotides in length.

4. The composition according to claim 1 , wherein the large DNA is a mammalian genomic DNA.

5. The composition according to claim 1 , wherein the large DNA is human genomic DNA.

6. The composition according to claim 1 , wherein the fragments are less than 60 nucleotides in size.

7. The composition according to claim 6 , wherein the fragments have a similar size in the range of 28-36 nucleotides.

8. The composition according to claim 1 , wherein the centrally positioned methylated or hydroxymethylated cytosine is located within 30 nucleotides from one end of the fragments.

9. The composition according to claim 1 , wherein the centrally positioned methylated or hydroxymethylated cytosine and guanine are in a CpG dinucleotide.

10. The composition according to claim 1 , wherein the centrally positioned methylated or hydroxymethylated cytosine and guanine are in a CNG trinucleotide.

Assignments (3)
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Sep 27, 2023
From: NEW ENGLAND BIOLABS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065044/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 1, 2019
From: ZHENG, YU; ROBERTS, RICHARD J.
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 049934/0524 →
CONFIRMATORY LICENSE Recorded Jun 9, 2016
From: NEW ENGLAND BIOLABS, INC
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 038926/0384 →